Hazard ratios. (A) PFS with regimens, including stem cell transplantation and novel agents; (B) OS with regimens, including stem cell transplantation and novel agents; (C) PFS with drug combinations, including novel agents; and (D) OS with drug combinations, including novel agents. Len indicates lenalidomide; NA, not available; and MP, melphalan-prednisone.